MedTrace Logo

Prophylactic Antimicrobial Catheter Lock

NCT00571259 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 303

Last updated 2021-09-22

Study results available
· View outcomes & findings →

Summary

This is a randomized, double blinded, prospective, multicenter, clinical trial of the use of Heparin versus Gentamicin as a pos-dialysis catheter lock solution.

Conditions

  • Bacteremia

Interventions

DRUG

Heparin 1000U/mL

A volume sufficient to fill the catheter length will be instilled in both catheter ports post dialysis

DRUG

4% Sodium Citrate with Gentamicin 320 mcg/mL

A volume sufficient to fill the catheter length will be instilled in both catheter ports post dialysis

Sponsors & Collaborators

  • Satellite Healthcare

    lead OTHER

Principal Investigators

  • Norman Coplon, MD · Satellite Healthcare, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-09-30
Primary Completion
2010-01-31
Completion
2010-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00571259 on ClinicalTrials.gov